Gregory T. Lucier
Chairman of the Board and Interim Chief Executive Officer
Gregory T. Lucier has served as our Chairman and Interim Chief Executive Officer since April 2015. He has served as a member of the NuVasive Board of Directors since December 2013. From May 2003 to February 2014, Mr. Lucier served as Chairman and Chief Executive Officer of Life Technologies, a global life sciences company acquired by Thermo Fisher Scientific in 2014. During Mr. Lucier’s 11-year tenure at Life Technologies, he led the company from a small start-up known as Invitrogen in 2003, directed the acquisition and merger of Invitrogen with Applied Biosystems in 2008 into the renamed Life Technologies, and then transformed the organization by 2013 into a global, world-leading biotechnology firm with 50,000 products, 12,000 employees and nearly $4 billion in sales in more than 180 countries. Serving in his leadership role, Mr. Lucier was responsible for fostering a culture of excellence at Life Technologies and applied his more than 25 years of strategic management experience to help champion an era of personalized medicine. Mr. Lucier previously was a Corporate Officer of General Electric and served as an executive at GE Medical Systems. He received a bachelor’s degree in engineering from Pennsylvania State University and a masters of business administration from Harvard Business School. In addition to serving on the Board of NuVasive, Mr. Lucier serves as the Board Chairman for Sanford Burnham Medical Research Institute and is a former director of CareFusion Corporation, now part of Becton, Dickinson & Co.